US 12,403,149 B2
Dispersible tablets of abiraterone acetate
Nijaguni Revansiddayya Rudraswamy Math, Bengaluru (IN); Sreenivasa Reddy, Bengaluru (IN); Ravi Vamsi Peri, Bengaluru (IN); and Shivakumar Pradeep, Bengaluru (IN)
Assigned to Shilpa Medicare Limited, Karnataka (IN)
Appl. No. 17/624,842
Filed by SHILPA MEDICARE LIMITED, Raichur (IN)
PCT Filed Jul. 2, 2020, PCT No. PCT/IB2020/056236
§ 371(c)(1), (2) Date Jan. 5, 2022,
PCT Pub. No. WO2021/009605, PCT Pub. Date Jan. 21, 2021.
Claims priority of application No. 201941015017 (IN), filed on Jul. 15, 2019.
Prior Publication US 2022/0257613 A1, Aug. 18, 2022
Int. Cl. A61K 9/20 (2006.01); A61K 9/00 (2006.01); A61K 31/58 (2006.01)
CPC A61K 31/58 (2013.01) [A61K 9/0056 (2013.01)] 10 Claims
 
1. A dispersible tablet comprising at least 70% w/w of abiraterone acetate and pharmaceutically acceptable excipients, wherein the dispersible tablet is free of binder.